Patents by Inventor Anja Kohlrausch

Anja Kohlrausch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DPP IV INHIBITOR FORMULATIONS
    Publication number: 20210260068
    Abstract: The present invention relates to pharmaceutical compositions of DPP IV inhibitors with an amino group, their preparation and their use to treat diabetes mellitus.
    Type: Application
    Filed: May 13, 2021
    Publication date: August 26, 2021
    Inventors: Anja KOHLRAUSCH, Patrick ROMER, Gerd SEIFFERT
  • DPP IV inhibitor formulations
    Patent number: 11033552
    Abstract: The present invention relates to pharmaceutical compositions of DPP IV inhibitors with an amino group, their preparation and their use to treat diabetes mellitus.
    Type: Grant
    Filed: March 19, 2019
    Date of Patent: June 15, 2021
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Anja Kohlrausch, Patrick Romer, Gerd Seiffert
  • DPP IV INHIBITOR FORMULATIONS
    Publication number: 20190209571
    Abstract: The present invention relates to pharmaceutical compositions of DPP IV inhibitors with an amino group, their preparation and their use to treat diabetes mellitus.
    Type: Application
    Filed: March 19, 2019
    Publication date: July 11, 2019
    Inventors: Anja KOHLRAUSCH, Patrick ROMER, Gerd SEIFFERT
  • DPP IV INHIBITOR FORMULATIONS
    Publication number: 20170312287
    Abstract: The present invention relates to pharmaceutical compositions of DPP IV inhibitors with an amino group, their preparation and their use to treat diabetes mellitus.
    Type: Application
    Filed: July 20, 2017
    Publication date: November 2, 2017
    Inventors: Anja KOHLRAUSCH, Patrick ROMER, Gerd SEIFFERT
  • DPP IV INHIBITOR FORMULATIONS
    Publication number: 20160022687
    Abstract: The present invention relates to pharmaceutical compositions of DPP IV inhibitors with an amino group, their preparation and their use to treat diabetes mellitus.
    Type: Application
    Filed: October 7, 2015
    Publication date: January 28, 2016
    Inventors: Anja KOHLRAUSCH, Patrick ROMER, Gerd SEIFFERT
  • Telmisartan sodium salt pharmaceutical formulation
    Patent number: 9029363
    Abstract: The invention relates to a pharmaceutical formulation of the crystalline sodium salt of 4?-[2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)benzimidazol-1-ylmethyl]biphenyl-2-carboxylic acid (telmisartan), and to processes for the preparation thereof.
    Type: Grant
    Filed: April 15, 2004
    Date of Patent: May 12, 2015
    Assignee: Boehringer Ingelheim International GmbH
    Inventor: Anja Kohlrausch
  • DPP IV INHIBITOR FORMULATIONS
    Publication number: 20130122089
    Abstract: The present invention relates to pharmaceutical compositions of DPP IV inhibitors with an amino group, their preparation and their use to treat diabetes mellitus.
    Type: Application
    Filed: January 7, 2013
    Publication date: May 16, 2013
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Anja Kohlrausch, Patrick Romer, Gerd Seiffert
  • DPP IV INHIBITOR FORMULATIONS
    Publication number: 20120219622
    Abstract: The present invention relates to pharmaceutical compositions of DPP IV inhibitors with an amino group, their preparation and their use to treat diabetes mellitus.
    Type: Application
    Filed: May 9, 2012
    Publication date: August 30, 2012
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Anja KOHLRAUSCH, Patrick ROMER, Gerd SEIFFERT
  • DPP IV INHIBITOR FORMULATIONS
    Publication number: 20120003313
    Abstract: The present invention relates to pharmaceutical compositions of DPP IV inhibitors with an amino group, their preparation and their use to treat diabetes mellitus.
    Type: Application
    Filed: September 12, 2011
    Publication date: January 5, 2012
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Anja KOHLRAUSCH, Patrick ROMER, Gerd SEIFFERT
  • DPP IV INHIBITOR FORMULATIONS
    Publication number: 20080107731
    Abstract: The present invention relates to pharmaceutical compositions of DPP IV inhibitors with an amino group, their preparation and their use to treat diabetes mellitus.
    Type: Application
    Filed: May 4, 2007
    Publication date: May 8, 2008
    Inventors: Anja Kohlrausch, Patrick Romer, Gerd Seiffert
  • Bilayer tablet of telmisartan and simvastatin
    Publication number: 20060078615
    Abstract: A bilayer tablet comprises a first layer formulated for instant release of the angiotensin II receptor antagonist telmisartan from a dissolving tablet matrix and a second layer formulated for instant release of the HMG-CoA reductase inhibitor simvastatin from a disintegrating or eroding tablet matrix.
    Type: Application
    Filed: September 28, 2005
    Publication date: April 13, 2006
    Applicant: Boehringer Ingelheim International GmbH
    Inventor: Anja Kohlrausch
  • Multilayer tablet
    Publication number: 20050186274
    Abstract: A multilayer tablet comprises a first layer formulated for instant release of the angiotensin II receptor antagonist telmisartan from a dissolving tablet matrix, a second layer formulated for instant release of the angiotensin converting enzyme inhibitor ramipril and optionally a diuretic from a disintegrating tablet matrix, and, optionally, a third layer formulated for instant release of a diuretic like hydrochlorothiazide from a fast disintegrating tablet matrix.
    Type: Application
    Filed: February 10, 2005
    Publication date: August 25, 2005
    Applicant: Boehringer Ingelheim International GmbH
    Inventor: Anja Kohlrausch
  • Tablet containing 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H- benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethylester or the salts thereof
    Publication number: 20050038077
    Abstract: A tablet comprising: (a) ethyl 3-[(2-{[4-(hexyloxycarbonylaminoiminomethyl)phenylamino]methyl}-1-methyl-1H-benzimidazole-5-carbonyl)pyridin-2-ylamino]propionate or a pharmaceutically acceptable salt thereof; (b) one or more pharmaceutically acceptable organic acids with a solubility in water of >1 g/250 mL at 20° C.; and (c) a pharmaceutically acceptable excipient or filler.
    Type: Application
    Filed: July 29, 2004
    Publication date: February 17, 2005
    Applicant: Boehringer Ingelheim International GmbH
    Inventor: Anja Kohlrausch
  • Tablets containing ambroxol
    Publication number: 20050027012
    Abstract: A tablet comprising a core portion comprising 150 mg to 1200 mg of ambroxol and a film coating surrounding the core portion.
    Type: Application
    Filed: July 9, 2004
    Publication date: February 3, 2005
    Applicant: Boehringer Ingelheim International GmbH
    Inventor: Anja Kohlrausch
  • Telmisartan sodium salt pharmaceutical formulation
    Publication number: 20050004107
    Abstract: The invention relates to a pharmaceutical formulation of the crystalline sodium salt of 4?-[2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)benzimidazol-1-ylmethyl]biphenyl-2-carboxylic acid (telmisartan), and to processes for the preparation thereof.
    Type: Application
    Filed: April 15, 2004
    Publication date: January 6, 2005
    Applicant: Boehringer Ingelheim International GmbH
    Inventor: Anja Kohlrausch